Neutralizing antibodies that recognize the human immunodeficiency virus gpl20 exterior envelope glyco-protein and are directed against either the third variable (V3) loop or conserved, discontinuous epitopes overlapping the CD4 binding region have been described. Here we report several observations that suggest a structural relationship between the V3 loop and amino acids in the fourth conserved (C4) gpl20 region that constitute part of the CD4 binding site and the conserved neutralization epitopes. Treatment of the gpl20 glycoprotein with ionic detergents resulted in a V3 loop-dependent masking of both linear C4 epitopes and discontinuous neutralization epitopes overlapping the CD4 binding site. Increased recognition of the native gpl20 gl...
Neutralizing antibodies often recognize regions of viral envelope glycoproteins that play a role in ...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
AbstractDifferent isolates of HIV-1 are known to vary in antibody binding and sensitivity to neutral...
Preservation of the conformation of recombinant gpl20 in an adjuvant, enabling it to elicit conforma...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
Abstract Background The CD4-induced (CD4i) epitopes in gp120 includes the co-receptor binding site, ...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
The CD4 molecule is a T cell surface glycoprotein that interacts with high affinity with the envelop...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
We have probed the structure of the C4 and V3 domains of human immunodeficiency virus type 1 gp120 b...
A number of linear and conformation-dependent neutralizing monoclonal antibodies (MAbs) have been ma...
Although the sequence variable loops of the human immunodeficiency virus' (HIV-1) surface envelope g...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The V3 region of the human immunodeficiency virus type 1 envelope protein gp120 constitutes a potent...
Neutralizing antibodies often recognize regions of viral envelope glycoproteins that play a role in ...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
AbstractDifferent isolates of HIV-1 are known to vary in antibody binding and sensitivity to neutral...
Preservation of the conformation of recombinant gpl20 in an adjuvant, enabling it to elicit conforma...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
Abstract Background The CD4-induced (CD4i) epitopes in gp120 includes the co-receptor binding site, ...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
The CD4 molecule is a T cell surface glycoprotein that interacts with high affinity with the envelop...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
We have probed the structure of the C4 and V3 domains of human immunodeficiency virus type 1 gp120 b...
A number of linear and conformation-dependent neutralizing monoclonal antibodies (MAbs) have been ma...
Although the sequence variable loops of the human immunodeficiency virus' (HIV-1) surface envelope g...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The V3 region of the human immunodeficiency virus type 1 envelope protein gp120 constitutes a potent...
Neutralizing antibodies often recognize regions of viral envelope glycoproteins that play a role in ...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...